COVID-19 vaccination immune response in patients with solid organ and haematologic malignancies: call for active monitoring

Vaccines against COVID-19 have demonstrated a remarkable efficacy in decreasing hospitalisations and deaths; however, clinical trials leading to vaccine approvals did not include immunocompromised individuals such as patients receiving antineoplastic therapies. Emerging data suggest that patients on...

Descripción completa

Detalles Bibliográficos
Autores principales: Chehade, Laudy, Zeitoun, Jad, Bejjany, Rachelle, Charafeddine, Maya, Kreidieh, Firas, Hassan, Mona, Taher, Ali, Saghir, Nagi El, Shamseddine, Ali, Salem, Ziad, Temraz, Sally, Tfayli, Arafat, Assi, Hazem, Bazarbachi, Ali, El Cheikh, Jean, Dalle, Iman Abou, Rizk, Nesrine, Mahfouz, Rami, Mukherji, Deborah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580593/
https://www.ncbi.nlm.nih.gov/pubmed/34824607
http://dx.doi.org/10.3332/ecancer.2021.1284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580593/
https://www.ncbi.nlm.nih.gov/pubmed/34824607
http://dx.doi.org/10.3332/ecancer.2021.1284

Ejemplares similares